LOMIDE

This brand name is authorized in New Zealand

Active ingredients

The drug LOMIDE contains one active pharmaceutical ingredient (API):

1 Lodoxamide UNII 50LV9A548L - LODOXAMIDE TROMETHAMINE

Lodoxamide is a mast cell stabiliser that inhibits the in vivo Type I immediate hypersensitivity reaction in animals and man. Read about Lodoxamide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LOMIDE Eye drops, solution	Medicines and Medical Devices Safety Authority (NZ)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01GX05	Lodoxamide	S Sensory organs → S01 Ophthalmologicals → S01G Decongestants and antiallergics → S01GX Other antiallergics
Discover more medicines within S01GX05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 7544